ROTARIX® (Rotavirus Vaccine, Live Oral): GSK’s PCV1 Investigation
ROTARIX® (Rotavirus Vaccine, Live Oral): GSK’s PCV1 Investigation. Barbara Howe, MD Vice President, Director North American Vaccine Development GlaxoSmithKline . Why We’re Here. Review data/information from unexpected finding of PCV1 in Rotarix
1.5k views • 76 slides